Acurx Pharmaceuticals's total assets for Q2 2025 were $6.16M, an increase of 28.14% from the previous quarter. ACXP total liabilities were $2.59M for the fiscal quarter, a 3.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.